Dr Patrick R Lahiff, DDS | |
116 N Meade Ave, Glendive, MT 59330-1604 | |
(734) 288-8799 | |
Not Available |
Full Name | Dr Patrick R Lahiff |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 116 N Meade Ave, Glendive, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144895848 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | DEN-DEN-LIC-21415 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Patrick R Lahiff, DDS 116 N Meade Ave, Glendive, MT 59330-1604 Ph: (734) 288-8799 | Dr Patrick R Lahiff, DDS 116 N Meade Ave, Glendive, MT 59330-1604 Ph: (734) 288-8799 |
News Archive
The Society of Toxicology (SOT) 51st Annual Meeting and ToxExpo - the largest meeting and expo of its kind anywhere in the world - will take place from March 11-15. The five-day program will feature more than 180 sessions, presenting the latest research findings and recommendations for remedial action on a wide range of issues affecting human and animal health and the environment.
At the start of the COVID-19 pandemic, stay-at-home orders and other restrictions drastically affected how people lived and worked, resulting in social isolation and economic instability. Now, researchers show that some people turned to a variety of drugs for relief. Using wastewater analysis, the team identified a spike in consumption of easily abused prescription opioids and anti-anxiety sedatives, while some illicit drug use plummeted, between March and June 2020.
Using CT scans to measure blood flow in the lungs of people who smoke may offer a way to identify which smokers are most at risk of emphysema before the disease damages and eventually destroys areas of the lungs, according to a University of Iowa study.
The need to enhance healthcare delivery is driving the market for IT professional services in Europe. Adoption levels are, however, being hampered by budget cuts and end user reluctance to invest in such services. These trends have triggered several changes in the market, including consolidation and the adoption of inorganic growth models.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).
› Verified 8 days ago
George R Carson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 116 N Meade Ave, Glendive, MT 59330 Phone: 406-377-8265 | |
Dr. Kevin Robert Mcpherson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 100 S Merrill Ave, Glendive, MT 59330 Phone: 406-365-1221 Fax: 406-365-1218 | |
Jason J. Roan, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 218 W Bell St Ste 102, Glendive, MT 59330 Phone: 406-377-2303 Fax: 406-377-3950 | |
Dr. Nathan Alfred Sickler, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 116 N Meade Ave, Glendive, MT 59330 Phone: 406-377-8265 | |
Matthew Don Calkins, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 116 N Meade Ave, Glendive, MT 59330 Phone: 406-377-8265 Fax: 406-377-8267 | |
Dr. Gary R Mintz, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 218 W Bell St, Suite 102, Glendive, MT 59330 Phone: 406-377-2303 Fax: 406-377-3950 |